Allianz Global Investors
Our Managers Commentary News & Media
Mutual Funds
Related Products
> Closed-End Funds
> 529 Plan

ALLIANZ FUNDS PROFILE 
All data as of 09.30.09, unless otherwise indicated. 
Allianz RCM Wellness Fund A (RAGHX)
Print

Fund Inception Date ** 12.31.96

 

Performance quoted represents past performance. Past performance is no guarantee of future results. Current performance may be lower or higher than average annual returns shown. Investment return and the principal value of an investment will fluctuate. Shares may be worth more or less than original cost when redeemed. MOP returns take into account the Class A maximum initial sales charge of 5.50%.

 

Effective September 4, 2008, the Allianz RCM Healthcare Fund changed its name to the Allianz RCM Wellness Fund. Effective October 17, 2008, the Allianz RCM Biotechnology Fund was reorganized with and into the Allianz RCM Wellness Fund.

About this Fund Performance Portfolio Review & Outlook Literature
Change Class  
Daily Performance (as of 11.05.09)
Daily NAV and Change
YTD
Returns
Annualized
NAV
$
%
1-yr
3-yr
5-yr
10-yr
$22.19
+$0.29
1.32%
22.26%
18.60%
-.53%
1.56%
-
Month-End Average Annual Returns (as of 09.30.09)
 
Allianz RCM Wellness A at NAV Lipper Health/Biotech Fund Avg.
 
1-yr
3-yr
5-yr
10-yr
Inception
Allianz RCM Wellness A at NAV
-.32%
-.53%
1.70%
8.30%
9.92%
Allianz RCM Wellness A at MOP
-5.80%
-2.38%
.55%
7.69%
9.43%
Lipper Health/Biotech Fund Avg.
-2.35%
.19%
3.46%
7.01%
8.17%
MSCI World Index
-2.29%
-4.35%
3.51%
.92%
4.18%
World Healthcare and Consumer Blended Benchmark
-.43%
-2.24%
3.52%
2.53%
2.59%
Quarter-End Average Annual Returns  (as of 09.30.09)
 
Allianz RCM Wellness A at NAV Allianz RCM Wellness A at MOP
 
1-yr
3-yr
5-yr
10-yr
Inception
Allianz RCM Wellness A at NAV
-.32%
-.53%
1.70%
8.30%
9.92%
Allianz RCM Wellness A at MOP
-5.80%
-2.38%
.55%
7.69%
9.43%
Lipper Health/Biotech Fund Avg.
-2.35%
.19%
3.46%
7.01%
8.17%
MSCI World Index
-2.29%
-4.35%
3.51%
.92%
4.18%
World Healthcare and Consumer Blended Benchmark
-.43%
-2.24%
3.52%
2.53%
2.59%
Calendar Year Returns  (benchmark data as of 09.30.09)
Allianz RCM Wellness A at NAV Lipper Health/Biotech Fund Avg.
 
'99
'00
'01
'02
'03
'04
'05
'06
'07
'08
'09YTD
Allianz RCM Wellness A at NAV
28.6%
73.2%
-13.9%
-26.7%
29.0%
12.7%
1.9%
0.6%
10.0%
-26.4%
20.8%
Lipper Health/Biotech Fund Avg.
22.8%
55.3%
-11.3%
-28.3%
34.3%
10.6%
10.6%
3.1%
10.4%
-22.9%
15.4%
MSCI World Index
25.0%
-13.2%
-16.8%
-19.9%
33.1%
14.7%
9.5%
20.1%
9.0%
-40.7%
24.9%
World Healthcare and Consumer Blended Benchmark
-5.4%
15.7%
-11.6%
-16.5%
21.8%
8.2%
7.4%
13.5%
4.9%
-25.0%
14.6%
Lipper Ranking  (based on total return)^   (as of 09.30.09)
 
1-yr
3-yr
5-yr
10-yr
Inception
Fund Rank
54
57
69
-
55
No. of Funds in Lipper Health/Biotech Fund Avg.
112
99
87
-
71
Quintile
3rd
3rd
4th
-
4th
Expense Ratio
 
Expense Ratio
Allianz RCM Wellness A
1.520%
Growth of $10,000 (as of 09.30.09) 
Fund Statistics  (as of 09.30.09)
 
Year-End NAV
Year-End Assets
in Millions
2009 YTD*
$21.92
$129
2008
$18.15
$134
2007
$24.67
$84
2006
$22.42
$100
2005
$22.29
$144
2004
$21.88
$188
2003
$19.42
$190
2002
$15.05
$143
2001
$20.52
$214
2000
$24.63
$254
1999
$14.28
$6
1998
$13.46
$5
1997
$11.69
$5

Investors should consider the investment objectives, risks, charges and expenses of this Fund carefully before investing. This and other information is contained in the Fund´s prospectus and summary prospectus, if available, which may be obtained by contacting your financial advisor, or by calling 888-877-4626. Click here for the Fund´s prospectus or summary prospectus. Please read them carefully before you invest or send money.

The daily section presents performance dating from the inception of the actual share class only.

 

**This is the inception date of the oldest share class, which for this Fund is the D share class. The returns presented are for Class A shares, which were first offered in 2/02. Returns measure performance from the inception of the oldest share class to the present, so some returns predate the inception of Class A. Those returns are calculated by adjusting the D share returns to reflect the A shares' different charges and expenses. Total return performance assumes that all dividend and capital gains distributions were reinvested on the payable date and does not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.

 

This Fund may invest at least 80% of its assets in the healthcare sector. This Fund may also invest in foreign securities, up to 15% in emerging market companies, IPOs, and smaller companies. Investing in foreign securities may entail risk due to foreign economic and political developments; this risk may be enhanced when investing in emerging markets. IPOs are subject to risk in that the securities have no trading history and the price may be volatile. Investments in smaller companies may be more volatile than investments in larger companies. This Fund may use derivative instruments for hedging purposes or as part of its investment strategy. Use of these instruments may involve certain costs and risks such as liquidity risk, interest rate risk, market risk, credit risk, management risk and the risk that a fund could not close out a position when it would be most advantageous to do so. Portfolios investing in derivatives could lose more than the principal amount invested in those instruments.

 

The Standard & Poors 500 Composite Index (S & P 500) is an unmanaged index that is generally representative of the U.S. stock market. The S&P 500 Healthcare Index is a market capitalization weighted index that represents the Health Care sector of the S&P 500 Index. Unless otherwise noted, index returns reflect the reinvestment of dividends and capital gains, if any, but do not reflect fees, brokerage commissions or other expenses of investing. It is not possible to invest directly in an index.

 

^The Lipper Category returns and rankings are calculated by Lipper Inc., a Reuters Company, which is a nationally recognized organization that compares the performance of mutual funds with similar investment objectives. The Category returns represent the average performance of included funds, while rankings compare an individual fund's returns to those of the other funds in its category. Both are based on total return performance, with capital gains and dividends reinvested, with annual operating expenses deducted, but without including front- or back-end sales charges. Rankings begin with the actual share class inception. Rankings are relative to a peer group and do not necessarily mean that the fund had high total returns.

 

Growth of $10,000 and Best/Worst 1-Year Period results are calculated at NAV and assume that all dividend and capital gain distributions were reinvested. They do not take into account sales charges or the effect of taxes. Results are not indicative of future performance.

 

PIMCO Funds & Allianz Funds are distributed by Allianz Global Investors Distributors LLC, 1345 Avenue of the Americas, New York, NY 10105-4800, www.allianzinvestors.com, 1-888-877-4626. NOT FDIC INSURED / MAY LOSE VALUE / NO BANK GUARANTEE

 


Advisor Login